Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$499.74 -9.01 (-1.77%)
At close: Oct 16, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Consolidated Net Income (2009 - 2026)

Updated

Vertex Pharmaceuticals' Consolidated Net Income was $1.1 billion in Q2 2026, up 6.5% from $1.03 billion a year earlier and up 6.6% from the prior quarter.

Analysis

Vertex Pharmaceuticals (VRTX) Consolidated Net Income (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vertex Pharmaceuticals' Consolidated Net Income was $4.41 billion through Jun 30, 2026, up 21.1% year-over-year; for FY2025, it came in at $3.95 billion.

  • Consolidated Net Income shows a five-year compound annual growth rate of 7.8% (FY2020 to FY2025).
  • In earlier years, Consolidated Net Income was -$535.6 million in FY2024, $3.62 billion in FY2023 (+9.0%), $3.32 billion in FY2022 (+41.8%) and $2.34 billion in FY2021 (-13.6%).
  • Quarterly Consolidated Net Income has moved between -$3.59 billion (Q2 2024) and $1.19 billion (Q4 2025) over five years.
  • Compared with a year earlier, Consolidated Net Income has increased for four straight quarters, with growth averaging 7.7% over the last seven quarters.
  • The best year-over-year quarter for Consolidated Net Income over five years was Q1 2026 (growth of 59.6%); the worst was Q1 2025 (a decline of 41.2%).
  • Per Business Quant data, VRTX's Consolidated Net Income in the three quarters before Q2 2026 was $1.03 billion (Q1 2026), $1.19 billion (Q4 2025) and $1.08 billion (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 5.53 Bn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn 3.62 Bn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 2.51 Bn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -10.50 Bn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -237.00 Mn
10 Vertex Pharmaceuticals 126.70 Bn 98.70 Bn 2.84 Bn 1.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.10 Bn
Mar 31, 2026 1.03 Bn
Dec 31, 2025 1.19 Bn
Sep 30, 2025 1.08 Bn
Jun 30, 2025 1.03 Bn
Mar 31, 2025 646.30 Mn
Dec 31, 2024 913.00 Mn
Sep 30, 2024 1.05 Bn
Jun 30, 2024 -3.59 Bn
Mar 31, 2024 1.10 Bn
Dec 31, 2023 968.80 Mn
Sep 30, 2023 1.04 Bn
Jun 30, 2023 915.70 Mn
Mar 31, 2023 699.80 Mn
Dec 31, 2022 818.90 Mn
Sep 30, 2022 930.50 Mn
Jun 30, 2022 810.50 Mn
Mar 31, 2022 762.10 Mn
Dec 31, 2021 770.10 Mn
Sep 30, 2021 851.90 Mn
API Access

Vertex Pharmaceuticals Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=VRTX&period=max&api_key=YOUR_API_KEY